Miscellaneous disorders involving the endometrium

Seminars in Diagnostic Pathology

Volumn 27, Issue 4, 2010, Pages 287-310

  McCluggage, W Glenn ^a  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

Endometritis; Endometrium; Hormones; Metaplasia; Polyps; Secondary malignancies

Indexed keywords

ESTROGEN; GESTAGEN; PROGESTERONE RECEPTOR MODULATOR; RALOXIFENE; TAMOXIFEN;

ACTINOBACTERIA; ADENOMYOMATOUS POLYP; ADENOMYOSIS; ADENOSARCOMA; ADIPOSE METAPLASIA; ARIAS STELLA PHENOMENON; ARTICLE; ARTIFACT; ATYPICAL POLYPOID ADENOMYOMA; BREAKTHROUGH BLEEDING; BREAST CANCER; CANCER RISK; CARCINOSARCOMA; CARTILAGINOUS METAPLASIA; CILIATED METAPLASIA; CLEAR CELL METAPLASIA; DIAGNOSTIC PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; ENDOMETRIAL DISEASE; ENDOMETRIAL EPITHELIAL METAPLASIA; ENDOMETRIAL GRANULOMA; ENDOMETRIAL MESENCHYMAL METAPLASIA; ENDOMETRIOSIS; ENDOMETRITIS; ENDOMETRIUM ABLATION; ENDOMETRIUM ATROPHY; ENDOMETRIUM BIOPSY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; ENDOMETRIUM POLYP; ENDOMETRIUM SARCOMA; ENDOMETRIUM TUMOR; EOSINOPHILIC METAPLASIA; ESTROGEN THERAPY; EXTRAMEDULLARY HEMATOPOIESIS; FIBROMA; GLIAL METAPLASIA; HOBNAIL CELL METAPLASIA; HUMAN; INFLAMMATORY CELL; INTRAUTERINE CONTRACEPTIVE DEVICE; LEIOMYOSARCOMA; LIGNEOUS ENDOMETRITIS; LYMPHOMA; MENOPAUSAL SYNDROME; MUCINOUS METAPLASIA; OSSEUS METAPLASIA; OVARY CARCINOMA; PAPILLARY SYNCYTIAL METAPLASIA; PATHOPHYSIOLOGY; PLASMA CELL; PRIORITY JOURNAL; RADIATION; RISK FACTOR; SMOOTH MUSCLE METAPLASIA; SQUAMOUS CELL METAPLASIA; UTERUS BLEEDING; UTERUS MYOMA;

FEMALE; HUMANS; UTERINE DISEASES;

EID: 78650108436     PISSN: 07402570     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semdp.2010.07.001     Document Type: Article

References (140)

1. Antoni J., Folch E., Costa J., et al. Comparison of cystopat and pipelle endometrial biopsy instruments. Eur J Obstet Gynecol Reprod Biol 1997, 72:57-61.
2. Archer D.F., McIntyre-Seltman K., Wilborn W.W., et al. Endometrial morphology in asymptomatic postmenopausal women. Am J Obstet Gynecol 1991, 165:317-320.
3. Clark T.J., Mann C.H., Shah N., et al. Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial hyperplasia. Acta Obstet Gynecol Scand 2001, 80:784-793.
4. Gordon S.J., Westgate J. The incidence and management of failed pipelle sampling in a general outpatient clinic. Aust N Z J Obstet Gynaecol 1999, 39:115-118.
5. Machado F., Moreno J., Carazo M., et al. Accuracy of endometrial biopsy with the Cornier pipelle for diagnosis of endometrial cancer and atypical hyperplasia. Eur J Gynaecol Oncol 2003, 24:279-281.
6. Bakour S.H., Khan K.S., Gupta J.K. Controlled analysis of factors associated with insufficient sample on outpatient endometrial biopsy. Br J Obstet Gynaecol 2000, 107:1312-1314.
7. Phillips V.P., McCluggage W.G. Results of a questionnaire regarding criteria for adequacy of endometrial biopsies. J Clin Pathol 2005, 58:417-419.
8. McCluggage W.G. My approach to the interpretation of endometrial biopsies and curettings. J Clin Pathol 2006, 59:801-812.
9. Clarke B., McCluggage W.G. Iatrogenic lesions and artefacts in gynaecological pathology. J Clin Pathol 2009, 62:104-112.
10. McKenna M., McCluggage W.G. Signet ring cells of stromal derivation in the uterine cervix secondary to cauterization: report of a previously undescribed phenomenon. J Clin Pathol 2008, 61:648-651.
11. Unger Z.M., Gonzalez J.L., Hannisian P.D., Schned A.R. Pseudolipomatosis in hysteroscopically resected tissues from the gynecologic tract: pathologic description and frequency. Am J Surg Pathol 2009, 33:1187-1190.
12. Smith M., Hagerty K.A., Skipper B., Bocklage T. Chronic endometritis: a combined histopathologic and clinical review of cases from 2002 to 2007. Int J Gynecol Pathol 2010, 29:44-50.
13. Bennett A.E., Rathmore S., Rhatigan R.M. Focal necrotizing endometritis: a clinicopathologic study of 15 cases. Int J Gynecol Pathol 1999, 18:220-225.
14. Adegboyega P.A., Pei Y., McLarty J. Relationship between eosinophils and chronic endometritis. Hum Pathol 2010, 41:33-37.
15. Leung A.S.Y., Vinyuvat S., Leong F.J.W.M., et al. Anti-CD38 and VS38 antibodies for detection of plasma cells in the diagnosis of chronic endometritis. Appl Immunohistochem Mol Morphol 1997, 5:189-193.
16. Bayer-Garner I.B., Korourian S. Plasma cells in chronic endometritis are easily identified when stained with syndecan-1. Mod Pathol 2001, 14:877-879.
17. Marshall R.J., Jones D.B. An immunohistochemical study of lymphoid tissue in human endometrium. Int J Gynecol Pathol 1988, 7:225-235.
18. Disep B., Innes B.A., Cochrane H.R., et al. Immunohistochemical characterization of endometrial leucocytes in endometritis. Histopathology 2004, 45:625-632.
19. Pritt B., Mount S.L., Cooper K., et al. Pseudoactinomycotic radiate granules of the gynaecological tract: review of a diagnostic pitfall. J Clin Pathol 2006, 59:17-20.
20. O'Brien P.K., Roth-Moyo L.A., Davis B.A. Pseudo-sulfur granules associated with intrauterine contraceptive devices. Am J Clin Pathol 1981, 75:822-825.
21. Boyle D.P., McCluggage W.G. Combined actinomycotic and pseudoactinomycotic radiate granules in the female genital tract: description of a series of cases. J Clin Pathol 2009, 62:1123-1126.
22. Young R.H., Harris N.L., Scully R.E. Lymphoma-like lesions of the lower female genital tract: a report of 16 cases. Int J Gynecol Pathol 1985, 4:289-299.
23. Geyer J.T., Ferry J.A., Harris N.L., et al. Florid reactive lymphoid hyperplasia of the lower female genital tract (lymphoma-like lesion): a benign condition that frequently harbors clonal immunoglobulin heavy chain gene rearrangements. Am J Surg Pathol 2010, 34:161-168.
24. Pearce K.F., Nolan T.A. Endometrial sarcoidosis as a cause of postmenopausal bleeding. J Reprod Med 1996, 41:878-888.
25. Scurry J., Planner R., Fortune D.W., et al. Ligneous (pseudomembranous) inflammation of the female genital tract. A report of two cases. J Reprod Med 1993, 38:407-412.
26. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA 1996, 275:370-375.
27. Grady D., Gebrestsadik T., Kerlikowske K., et al. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 1995, 85:304-313.
28. Paganini-Hill A., Ross R.K., Henderson B.E. Endometrial cancer and patterns of oestrogen replacement therapy. Cancer 1989, 59:445-447.
29. Brinton L.A., Hoover R.N. Estrogen replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 1993, 81:265-271. Endometrial Cancer Collaborative Group.
30. Shapiro S., Kelly J.P., Rosenberg L., et al. Risk of localized and widespread endometrial cancer in relation to recent and discontinued use of conjugated estrogens. N Engl J Med 1985, 313:969-972.
31. Sturdee D.W., Ulrich L.G., Barlow D.H., et al. The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy. Br J Obstet Gynaecol 2000, 107:1392-1400.
32. Nand S.L., Webster M.A., Baber R., et al. Bleeding pattern and endometrial changes during continuous combined hormone replacement therapy. Obstet Gynecol 1998, 91:678-684.
33. Feeley K.M., Wells M. Hormone replacement therapy and the endometrium. J Clin Pathol 2001, 54:435-440.
34. Staland B. Continuous treatment with natural oestrogens and progestagens. A method to avoid endometrial stimulation. Maturitas 1981, 3:145-156.
35. Clement P.B., Scully R.E. Idiopathic postmenopausal decidual reaction of the endometrium. Int J Gynecol Pathol 1988, 7:152-161.
36. Mutter G.L., Bergeron C., Deligdish L., et al. The spectrum of endometrial pathology induced by progesterone receptor modulators. Mod Pathol 2008, 21:591-598.
37. Fisher B., Consantino J.P., Wickerham D.L., et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998, 90:1371-1388.
38. Ismail S.M. Pathology of endometrium treated with tamoxifen. J Clin Pathol 1994, 47:827-833.
39. Ismail S.M. Gynaecological effects of tamoxifen. J Clin Pathol 1999, 52:83-88.
40. Seidman J.D., Kurman R.J. Tamoxifen and the endometrium. Int J Gynecol Pathol 1999, 18:293-296.
41. Cheng W.F., Lin H.H., Torng P.L., et al. Comparison of endometrial changes among symptomatic tamoxifen-treated and non-treated premenopausal and postmenopausal breast cancer patients. Gynecol Oncol 1997, 66:233-237.
42. Hachisuga T., Hideshima T., Kawarabayashi T., et al. Expression of steroid receptors, Ki-67 and epidermal growth factor receptor in tamoxifen-treated endometrium. Int J Gynecol Pathol 1999, 18:297-303.
43. Cohen I., Figer A., Altaras M.M., et al. Common endometrial decidual reaction in postmenopausal breast cancer patients treated with tamoxifen and progestogens. Int J Gynecol Pathol 1996, 5:17-22.
44. Kennedy M.M., Baigrie C.F., Manek S. Tamoxifen and the endometrium: review of 102 cases and comparison with HRT-related and non-HRT-related endometrial pathology. Int J Gynecol Pathol 1999, 18:130-137.
45. Schlesinger C., Kamoi S., Ascher S.M., et al. Endometrial polyps: a comparison study of patients receiving tamoxifen with two control groups. Int J Gynecol Pathol 1998, 17:302-311.
46. McCluggage W.G., Sumathi V.P., McManus D.T. Uterine serous carcinoma and endometrial intraepithelial carcinoma arising in endometrial polyps: report of 5 cases, including 2 associated with tamoxifen therapy. Hum Pathol 2003, 34:939-943.
47. Silva E.G., Jenkins R. Serous carcinoma in endometrial polyps. Mod Pathol 1999, 3:120-128.
48. Houghton J., Ioffe O., Silverberg S.G., McGrady B., McCluggage W.G. Metastatic breast lobular carcinoma involving tamoxifen-associated endometrial polyps: report of two cases and review of tamoxifen-associated polypoid uterine lesions. Mod Pathol 2003, 16:395-398.
49. Cohen I., Beyth Y., Shapira J., et al. High frequency of adenomyosis in postmenopausal breast cancer patients treated with tamoxifen. Gynecol Obstet Invest 1997, 44:200-205.
50. McCluggage W.G., Desai V., Manek S. Tamoxifen-associated postmenopausal adenomyosis exhibits stromal fibrosis, glandular dilatation and epithelial metaplasias. Histopathology 2000, 37:340-346.
51. Turbiner J., Moreno-Bueno G., Dahiya S., et al. Clinicopathological and molecular analysis of endometrial carcinoma associated with tamoxifen. Mod Pathol 2008, 21:925-936.
52. McCluggage W.G. Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?. J Clin Pathol 2002, 55:321-325.
53. McCluggage W.G., Abdulkader M., Price J.H., et al. Uterine carcinosarcomas in patients receiving tamoxifen. A report of 19 cases. Int J Gynecol Cancer 2000, 10:280-284.
54. Shibutani S., Ravindernath A., Suzuki N., et al. Identification of tamoxifen-DNA adducts in the endometrium of women treated with tamoxifen. Carcinogenesis 2000, 21:1461-1467.
55. Clement P.B., Oliva E., Young R.H. Mullerian adenosarcoma of the uterine corpus associated with tamoxifen therapy: a report of six cases and a review of tamoxifen-associated endometrial lesions. Int J Gynecol Pathol 1996, 15:222-229.
56. Huang K.T., Chen C.A., Cheng W.F., et al. Sonographic characteristics of adenofibroma of the endometrium following tamoxifen therapy for breast cancer: two case reports. Ultrasound Obstet Gynecol 1996, 7:363-366.
57. McCluggage W.G., Varma V., Weir P., et al. Uterine leiomyosarcoma in patient receiving tamoxifen therapy. Acta Obstet Gynecol Scand 1996, 75:593-595.
58. Delmas P.D., Bjarnson N.H., Mitlak B.H., et al. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med 1997, 337:1641-1647.
59. Hendrickson M.R., Kempson R.L. Endometrial epithelial metaplasias: proliferations frequently misdiagnosed as adenocarcinoma. Report of 89 cases and proposed classification. Am J Surg Pathol 1980, 4:525-542.
60. McCluggage W.G. Metaplasias in the female genital tract. Recent Advances in Histopathology: 20 2003, Royal Society of Medicine Press, London. D. Lowe, J. Underwood (Eds.).
61. Wheeler D.T., Bristow R.E., Kurman R.J. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins. Am J Surg Pathol 2007, 31:988-998.
62. Carlson J.W., Mutter G.L. Endometrial intraepithelial neoplasia is associated with polyps and frequently has metaplastic change. Histopathology 2008, 53:325-332.
63. Quddus M.R., Sung C.J., Zheng W., et al. p53 immunoreactivity in endometrial metaplasia with dysfunctional uterine bleeding. Histopathology 1999, 35:44-49.
64. O'Connell J.T., Mutter G.L., Cviko A., et al. Identification of a basal/reserve cell immunophenotype in benign and neoplastic endometrium: a study with the p53 homologue p63. Gynecol Oncol 2001, 80:30-36.
65. Stasny J.F., Ben-Ezra J., Stewart J.A., et al. Condyloma and cervical intraepithelial neoplasia of the endometrium. Gynecol Obstet Invest 1995, 39:277-280.
66. Pins M.R., Young R.H., Crum C.P., et al. Cervical squamous cell carcinoma in situ with intraepithelial extension to the upper genital tract and invasion of tubes and ovaries: report of a case with human papillomavirus analysis. Int J Gynecol Pathol 1997, 16:272-278.
67. Dutra F. Intraglandular morules of the endometrium. Am J Clin Pathol 1959, 31:60-65.
68. Brachtel E.F., Sánchez-Estevez C., Moreno-Bueno G., et al. Distinct molecular alterations in complex endometrial hyperplasia (CEH) with and without immature squamous metaplasia (squamous morules). Am J Surg Pathol 2005, 29:1322-1329.
69. Saegusa M., Okayasu I. Frequent nuclear beta-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation. J Pathol 2001, 194:59-67.
70. Houghton O., Connolly L.E., McCluggage W.G. Morules in endometrioid proliferations of the uterus and ovary consistently express the intestinal transcription factor CDX2. Histopathology 2008, 53:156-165.
71. Chiarelli S., Buriticá C., Litta P., et al. An immunohistochemical study of morules in endometrioid lesions of the female genital tract: CD10 is a characteristic marker of morular metaplasia. Clin Cancer Res 2006, 12:4251-4256.
72. Chinen K., Kamiyama K., Kinjo T., et al. Morules in endometrial carcinoma and benign endometrial lesions differ from squamous differentiation tissue and are not infected with human papillomavirus. J Clin Pathol 2004, 57:918-926.
73. Wani Y., Notohara K., Saegusa M., et al. Aberrant Cdx2 expression in endometrial lesions with squamous differentiation: important role of Cdx2 in squamous morula formation. Mod Pathol 2008, 39:1072-1079.
74. Wells M., Tiltman A. Intestinal metaplasia of the endometrium. Histopathology 1989, 5:431-433.
75. McCluggage W.G., Roberts N., Bharucha H. Enteric differentiation in endometrial adenocarcinomas: a mucin histochemical study. Int J Gynecol Pathol 1995, 14:250-254.
76. Vang R., Tavassoli F.A. Proliferative mucinous lesions of the endometrium: analysis of existing criteria for diagnosing carcinoma in biopsies and curettings. Int J Surg Pathol 2003, 11:261-270.
77. Nucci M.R., Prasad C.J., Crum C.P., et al. Mucinous endometrial epithelial proliferations: A morphologic spectrum of changes with diverse clinical significance. Mod Pathol 1999, 12:1137-1142.
78. Baird D.B., Reddick R.L. Extraovarian mucinous metaplasia in a patient with bilateral mucinous borderline ovarian tumors: a case report. Int J Gynecol Pathol 1991, 10:96-103.
79. Mikami Y., Kiyokawa T., Sasajima Y., et al. Reappraisal of synchronous and multifocal mucinous lesions of the female genital tract: a close association with gastric metaplasia. Histopathology 2009, 54:184-191.
80. Seidman J.D. Mucinous lesions of the Fallopian tube. A report of seven cases. Am J Surg Pathol 1994, 18:1205-1212.
81. Shah S.S., Mazur M.T. Endometrial eosinophilic syncytial change related to breakdown: immunohistochemical evidence suggests a regressive process. Int J Gynecol Pathol 2008, 27:534-538.
82. Huettner P.C., Gersell D.J. Arias-Stella reaction in nonpregnant women: a clinicopathologic study of nine cases. Int J Gynecol Pathol 1994, 13:241-247.
83. Lehman M.B., Hart W.R. Simple and complex hyperplastic papillary proliferations of the endometrium: a clinicopathologic study of nine cases of apparently localized papillary lesions with fibrovascular stromal cores and epithelial metaplasia. Am J Surg Pathol 2002, 25:1347-1354.
84. Bahceci M., Demirel L.C. Osseous metaplasia of the endometrium: a rare cause of infertility and its hysteroscopic management. Hum Reprod 1996, 11:2537-2539.
85. McCluggage W.G., Hamal P., Traub A.I., et al. Uterine adenolipoleiomyoma: a rare hamartomatous lesion. Int J Gynecol Pathol 2000, 19:183-185.
86. Creagh T.M., Bain B.J., Evans D.J., et al. Endometrial extramedullary haematopoiesis. J Pathol 1995, 176:99-104.
87. Gru A.A., Hassan A., Pfeifer J.D., et al. Uterine extramedullary hematopoesis: what is the clinical significance?. Int J Gynecol Pathol 2010, 29:366-373.
88. Schindler A.E., Schmidt G. Postmenopausal bleeding: a study of more than 1000 cases. Maturitas 1980, 2:269-274.
89. Fletcher J.A., Pinkus G.S., Donovan K., et al. Clonal rearrangement of chromosome band 6p21 in the mesenchymal component of pulmonary chondroid hamartoma. Cancer Res 1992, 52:6224-6228.
90. Dal Cin P., De Wolf F., Klerckx P., et al. The 6p21 chromosome region is nonrandomly involved in endometrial polyps. Gynecol Oncol 1992, 46:393-396.
91. De Quintall M.M., De Angelo Andrade L.A. Endometrial polyp with sex cord-like pattern. Int J Gynecol Pathol 2006, 25:170-172.
92. Tai L.H., Tavassoli F.A. Endometrial polyps with atypical (bizarre) stromal cells. Am J Surg Pathol 2002, 26:505-509.
93. Shah R., McCluggage W.G. Symplastic atypia in neoplastic and non-neoplastic endometrial stroma: report of 3 cases with a review of atypical symplastic cells within the female genital tract. Int J Gynecol Pathol 2009, 28:334-337.
94. Gilks C.B., Clement P.B., Hart W.R., et al. Uterine adenomyomas excluding atypical polypoid adenomyomas and adenomyomas of endocervical type: a clinicopathologic study of 30 cases of an underemphasized lesion that may cause diagnostic problems with brief consideration of adenomyomas of other female genital tract sites. Int J Gynecol Pathol 2000, 19:195-205.
95. Tahlan A., Nanda A., Mohan H. Uterine adenomyoma: a clinicopathologic review of 26 cases and a review of the literature. Int J Gynecol Pathol 2006, 25:361-365.
96. Kelly P., Dobbs S.P., McCluggage W.G. Endometrial hyperplasia involving endometrial polyps: report of a series and discussion of the significance in an endometrial biopsy specimen. Br J Obstet Gynaecol 2007, 114:944-950.
97. Mittal K., Da Costa M. Endometrial hyperplasia and carcinoma in endometrial polyps: clinicopathologic and follow-up findings. Int J Gynecol Pathol 2008, 27:45-48.
98. Hui P., Kelly M., O'Malley D.M., et al. Minimal uterine serous carcinoma: a clinicopathological study of 40 cases. Mod Pathol 2005, 18:75-82.
99. Mazur M.T. Atypical polypoid adenomyomas of the endometrium. Am J Surg Pathol 1981, 5:473-482.
100. Young R.H., Treger T., Scully R.E. Atypical polypoid adenomyoma of the uterus. A report of 27 cases. Am J Clin Pathol 1986, 86:139-145.
101. Longacre T.A., Chung M.H., Rouse R.V., et al. Atypical polypoid adenomyofibromas (atypical polypoid adenomyomas) of the uterus. A clinicopathologic study of 55 cases. Am J Surg Pathol 1996, 20:1-20.
102. Clement P.B., Young R.H. Atypical polypoid adenomyoma of the uterus associated with Turner's syndrome. Int J Gynecol Pathol 1987, 6:104-113.
103. Soslow R.A., Chung M.H., Rouse R.V., et al. Atypical polypoid adenomyofibroma (APA) versus well-differentiated endometrial carcinoma with prominent stromal matrix: an immunohistochemical study. Int J Gynecol Pathol 1996, 15:209-216.
104. Ohishi Y., Kaku T., Kobayashi H., et al. CD10 immunostaining distinguishes atypical polypoid adenomyofibroma (atypical polypoid adenomyoma) from endometrial carcinoma invading the myometrium. Hum Pathol 2008, 39:1446-1453.
105. Ota S., Catasus L., Matias-Guiu X., et al. Molecular pathology of atypical polypoid adenomyoma of the uterus. Hum Pathol 2003, 34:784-788.
106. Heatley M.K. Atypical polypoid adenomyoma: a systematic review of the English literature. Histopathology 2006, 48:609-610.
107. Gardner F.J., Konje J.C., Bell S.C., et al. Prevention of tamoxifen induced endometrial polyps using a levonorgestrel intrauterine system: long term follow up of a randomised control trial. Gynecol Oncol 2009, 114:452-456.
108. Phillips V., Graham C.T., Manek S., et al. The effects of the levonorgestrel intrauterine system (Mirena coil) on endometrial morphology. J Clin Pathol 2003, 56:305-307.
109. Hejmadi R.K., Chaudhri S., Ganesan R., et al. Morphologic changes in the endometrium associated with the use of the mirena coli: a retrospective study of 106 cases. Int J Surg Pathol 2007, 15:148-154.
110. Seidman J.D., Kumar D., Cosin J.A., et al. Carcinomas of the female genital tract occurring after pelvic irradiation: a report of 15 cases. Int J Gynecol Pathol 2006, 25:293-297.
111. Colgan T.J., Shah R., Leyland N. Post-hysteroscopic ablation reaction: a histopathologic study of electrosurgical ablation. Int J Gynecol Pathol 1999, 18:325-331.
112. Ferryman S.R., Stephens M., Gough D. Necrotising granulomatous endometritis following endometrial ablation therapy. Br J Obstet Gynaecol 1992, 99:928-930.
113. McCullough T.A., Wagner B., Duffy S., et al. The pathology of hysterectomy specimens following transcervical resection of the endometrium. Histopathology 1995, 27:541-547.
114. Mazur M., Hsueh S., Gersell D. Metastases to the female genital tract. Cancer 1984, 53:1978-1984.
115. Yemelanova A., Vang R., Seidman J.D., et al. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor. Am J Surg Pathol 2009, 33:914-924.
116. McCluggage W.G., Sumathi V.P., McBride H.A., et al. A panel of immunohistochemical stains including carcinoembryonic antigen, vimentin and estrogen receptor aids the distinction between primary endometrial and endocervical adenocarcinomas. Int J Gynecol Pathol 2002, 21:11-15.
117. Castrillon D.H., Lee K.R., Nucci M.R. Distinction between endometrial and endocervical adenocarcinoma: an immunohistochemical study. Int J Gynecol Pathol 2002, 21:4-10.
118. McCluggage W.G., Jenkins D. p16 immunoreactivity may assist in the distinction between endometrial and endocervical adenocarcinoma. Int J Gynecol Pathol 2003, 22:231-235.
119. Yemelyanova A., Ji H., Shih I.M., et al. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases. Am J Surg Pathol 2009, 33:1504-1514.
120. Chiesa-Vottero A.G., Malpica A., Deavers M.T., et al. Immunohistochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma. Int J Gynecol Pathol 2007, 26:328-333.
121. Ambros R.A., Sherman M.E., Zahn C.M., et al. Endometrial intraepithelial carcinoma: distinctive lesion specifically associated with tumors displaying serous differentiation. Hum Pathol 1995, 26:1260-1267.
122. Wheeler D.T., Bell K.A., Kurman R.J., et al. Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation. Am J Surg Pathol 2000, 24:797-806.
123. Goldstein N.S., Uzieblo A. WT-1 immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas. Am J Clin Pathol 2002, 117:541-545.
124. Al-Hussaini M., Stockman A., Foster H., et al. WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma. Histopathology 2004, 44:109-115.
125. McCluggage W.G. WT1 is of value in ascertaining the site of origin of serous carcinomas within the female genital tract. Int J Gynecol Pathol 2004, 23:97-99.
126. Egan J.A., Ionescu M.C., Eapen E., et al. Can analysis of p53 and WT1 assist in distinguishing uterine serous carcinoma from uterine endometrioid carcinoma?. Int J Gynecol Pathol 2004, 23:119-122.
127. Acs G., Pasha T., Zhang P.J. WT1 is expressed in serous, but not in endometrioid, clear cell or mucinous carcinoma of the peritoneum, fallopian tube, ovaries and endometrium. Int J Gynecol Pathol 2004, 23:110-118.
128. Hashi A., Yuminamochi T., Murata S., et al. Wilms' tumor gene immunoreactivity in primary serous carcinomas of the Fallopian tube, ovary, endometrium and peritoneum. Int J Gynecol Pathol 2003, 22:374-377.
129. Hirschowitz L., Ganesan R., McCluggage W.G. WT1, p53 and hormone receptor expression in uterine serous carcinoma. Histopathology 2009, 55:478-482.
130. McCluggage W.G. Problematic areas in the reporting of endometrial carcinomas in hysterectomy specimens. Diagn Histopathol 2009, 15:571-581.
131. Singh N. Synchronous tumours of the female genital tract. Histopathology 2010, 56:277-285.
132. Kumar A., Schneider V. Metastases to the uterus from extrapelvic primary tumors. Int J Gynecol Pathol 1983, 2:134-140.
133. Kumar N.B., Hart W.R. Metastases to the uterine corpus from extragenital cancers. A clinicopathologic study of 63 cases. Cancer 1982, 50:2163-2169.
134. Iezonni J.C., Mills S.E. Nonneoplastic endometrial signet-ring cells. Vacuolated decidual cells and stromal histiocytes mimicking adenocarcinoma. Am J Clin Pathol 2001, 115:249-255.
135. Onuma K., Dabbs D.J., Bhargava R. Mammaglobin expression in the female genital tract: immunohistochemical analysis in benign and neoplastic endocervix and endometrium. Int J Gynecol Pathol 2008, 27:418-425.
136. Khoury S., Odeh M., Ophir E., et al. Uterine metastasis from gastric cancer. Acta Obstet Gynecol Scand 1997, 76:803.
137. Leiberman J., Chaim W., Cohen A., Czernobilsky B. Primary carcinoma of stomach with uterine metastasis. Br J Obstet Gynaecol 1975, 82:917-921.
138. Moore W.F., Bentley R.C., Kim K.-Y., et al. Goblet-cell mucinous epithelium lining the endometrium and endocervix: evidence of metastases from an appendiceal primary tumor through the use of cytokeratin 7 and 20 immunostains. Int J Gynecol Pathol 1998, 17:363-367.
139. Bauer R.D., McCoy C.P., Roberts D.K., et al. Malignant melanoma metastatic to the endometrium. Obstet Gynecol 1984, 63:264-268.
140. Luxman D., Jossiphov J., Cohen J.R., et al. Uterine metastasis from vulvar malignant melanoma. A case report. J Reprod Med 1997, 42:244-246.